纳斯法-1的抗滴素作用需要激活GLP-1受体
Colleen R Bocke1, Gina L C Yosten1, Willis K Samson1
1Department of Pharmacology and Physiology, Institute for Translational NeuroscienceSaint Louis University School of Medicine, St. Louis, Missouri, United States.
概括
纳斯法-1 抑制水的摄入,其抗滴素效应依赖于类似葡萄糖-1 (GLP-1) 的受体神经元. 这揭示了一个新的神经回路来调节摄入液体.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 生理学 生理学 生理学
背景情况:
- 涅斯法-1 抑制食物和水的摄入.
- 类似葡萄糖类-1 (GLP-1) 的作用涉及纳斯法丁-1神经元.
- 多个神经相互作用以控制摄入行为.
研究的目的:
- 调查GLP-1信号传递在内斯法-1抗滴素作用中的作用.
- 为了阐明纳斯法-1对摄入水的作用背后的神经回路.
主要方法:
- 纳斯法-1和GLP-1抗剂 (exendin-3) 的使用.
- 在药理干预后评估水摄入量.
- 对涉及的神经信号通路的分析.
主要成果:
- 纳斯法-1的抗滴素效应被GLP-1抗剂逆转.
- 纳斯法-1对饮用水的作用取决于GLP-1受体表达神经元.
- 之前的研究表明,通过阻断黑色皮质素,皮质otropin释放因子和催产素信号传递,nesfatin的作用被废止.
结论:
- 纳斯法廷-1的水摄入抑制是由GLP-1受体神经元介导的.
- 一个涉及nesfatin-1和其他的新型神经回路调节液体摄入.
相关概念视频
Glucagon-like Receptor Agonists
415
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
415
Oral Hypoglycemic Agents: Glinides
256
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
256
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Regulation of Food Intake
339
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
339
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Dipeptidyl Peptidase 4 Inhibitors
249
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
249


